ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
현기증 치료 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 5.7%로 21억 달러로 성장할 것으로 예상됩니다. 예측기간의 성장은 임상시험수 증가, 신약의 출현, 정부의 이니셔티브 증가, 의약품의 이용 가능성의 확대, 뇌간장애의 유병률 증가 등에 기인하고 있습니다. 이 기간의 주요 동향으로는 신규 현기증 관련 치료제 개발, 원격 의료 서비스 확대, 장비 기반 치료 진전, 기술 혁신, 전략적 제휴 등이 있습니다.
스포츠 관련 부상 증가 추세는 현기증 치료 시장의 성장을 크게 촉진하고 있습니다. 스포츠 관련 상해는 스포츠 활동과 육체적인 운동 중에 부담되는 것으로, 충격이 큰 스포츠에의 참가 증가, 격렬한 트레이닝 처방, 불충분한 상해 예방 대책을 위해 일반적으로 되고 있습니다. 이러한 부상은 종종 평형 감각 장애와 현기증을 유발하며 약물 요법, 전정 재활 요법 및 생활 습관 개선을 포함한 현기증 치료가 필요합니다. 이러한 치료로 운동 선수는 더 빨리 회복하고, 협조성을 되찾고, 스포츠 활동에 안전하게 복귀 할 수 있습니다. 미국 도로교통안전청에 따르면 2024년 7월 2022년 페달 자전거 사망 사고는 13% 증가했으며 2021년 976건에서 1,105건으로 증가했습니다. 게다가 2022년에 부상을 입은 자전거 이용자는 4만 6,195명으로 추정되며 2021년 4만 1,615명에서 11% 증가했습니다. 이러한 부상의 급증은 효과적인 현기증 치료에 대한 수요 증가를 뒷받침합니다.
현기증 치료, 특히 디지털 헬스 솔루션의 기술적 진보는 시장 확대를 더욱 촉진하고 있습니다. Coach 앱을 발표하고 개인의 현기증 관리를 지원하는 디지털 플랫폼을 제공했습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 현기증 치료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 현기증 치료 시장 : 성장률 분석
세계의 현기증 치료 시장 실적 : 규모와 성장, 2019-2024
세계의 현기증 치료 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 현기증 치료 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 현기증 치료 시장 : 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
말초 현기증
중앙 현기증
세계의 현기증 치료 시장 : 치료별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
약
수술
치료
세계의 현기증 치료 시장 : 투여 경로별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
오랄
주제
비경구
기타 투여 경로
세계의 현기증 치료 시장 : 최종 사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
병원
클리닉
기타 최종 사용자
세계의 현기증 치료 시장 : 말초성 현기증 분류(유형별), 분석과 예측, 2019-2024, 2024-2029F, 2034F
양성 발작성 두위 현기증(BPPV)
메니에르병
전정 신경염
미로염
세계의 현기증 치료 시장 : 중추성 현기증 분류(유형별), 분석과 예측, 2019-2024, 2024-2029F, 2034F
전정성 편두통
뇌졸중에 따른 현기증
다발성 경화증 관련 현기증
뇌종양 관련 현기증
제7장 지역별/국가별 분석
세계의 현기증 치료 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
세계의 현기증 치료 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
현기증 치료 시장 : 경쟁 구도
현기증 치료 시장 : 기업 프로파일
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
Boston Scientific Corp. Overview, Products and Services, Strategy and Financial Analysis
Eisai Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업 및 혁신 기업
Lupin Ltd.
Vertigenius
Kracie Holdings Ltd.
Biologische Heilmittel Heel GmbH
Interacoustics A/S.
AdvaCare Pharma
AuroPharma Inc.
Biofield Pharma Pvt Ltd.
Sound Pharmaceuticals Inc.
Otolith Labs Inc.
Ear Technology Corporation
NeuroEquilibrium Diagnostic Systems Pvt Ltd.
Vestibular First
Natus Medical Incorporated
Ronish Bioceuticals
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
현기증 치료 시장(2029년) : 새로운 기회를 제공하는 국가
현기증 치료 시장(2029년) : 새로운 기회를 제공하는 부문
현기증 치료 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
SHW
영문 목차
영문목차
Vertigo treatment involves medical interventions designed to alleviate symptoms such as dizziness and balance issues. It includes medications, physical therapy, and lifestyle modifications to manage the underlying causes, helping to improve balance, reduce dizziness, and prevent vertigo episodes. This treatment is used for conditions such as benign paroxysmal positional vertigo (BPPV), vestibular disorders, and other related conditions.
The main types of vertigo treatment are peripheral vertigo and central vertigo. Peripheral vertigo results from issues in the inner ear or the vestibular nerve, which connects the inner ear to the brain. Treatment options include medication, surgery, and therapy, administered through oral, topical, parenteral, and other routes. These treatments are utilized by various end users, including hospitals, clinics, and other healthcare facilities.
The vertigo treatment market research report is one of a series of new reports from The Business Research Company that provides vertigo treatment market statistics, including vertigo treatment industry global market size, regional shares, competitors with a vertigo treatment market share, detailed vertigo treatment market segments, market trends and opportunities, and any further data you may need to thrive in the vertigo treatment industry. This vertigo treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The vertigo treatment market size has grown strongly in recent years. It will grow from $1.58 billion in 2024 to $1.68 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to the increasing geriatric population, rising healthcare expenditure, growing investments in research and development, a higher incidence of vertigo cases, and greater awareness of ear-related conditions.
The vertigo treatment market size is expected to see strong growth in the next few years. It will grow to $2.10 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to the increasing number of clinical trials, the emergence of new drugs, rising government initiatives, greater availability of medications, and a growing prevalence of brain stem disorders. Key trends during this period include the development of novel vertigo-related therapeutics, the expansion of telehealth services, advancements in device-based therapies, technological innovations, and strategic collaborations.
The rising prevalence of sports-related injuries is significantly driving the growth of the vertigo treatment market. Sports-related injuries, sustained during athletic activities or physical exertion, have become more common due to increased participation in high-impact sports, intense training regimens, and inadequate injury prevention measures. These injuries often lead to balance disorders and dizziness, necessitating vertigo treatments that include medications, vestibular rehabilitation therapy, and lifestyle modifications. Such treatments help athletes recover faster, regain coordination, and safely return to sports activities. According to the National Highway Traffic Safety Administration, in July 2024, there was a 13% increase in pedal cyclist fatalities in 2022, rising from 976 in 2021 to 1,105. Additionally, an estimated 46,195 pedal cyclists sustained injuries in 2022, reflecting an 11% rise from 41,615 in 2021. This surge in injuries underscores the growing demand for effective vertigo treatments.
Technological advancements in vertigo treatment, particularly through digital health solutions, are further driving market expansion. Digital health solutions leverage technology-driven tools to improve health management, diagnosis, and treatment adherence. In August 2023, Abbott Laboratories introduced the Vertigo Coach app in India, offering a digital platform to help individuals manage vertigo. The app provides resources, exercises, lifestyle recommendations, and medication reminders, enhancing patient-physician communication and improving adherence to treatment plans. Such innovations contribute to more accessible and effective vertigo management.
In April 2023, Marksans Pharma acquired an Indian manufacturing facility from Teva Pharmaceutical Industries, expanding its production capacity from 8 billion units per year. This acquisition enables the company to produce a broader range of pharmaceutical products, including tablets, capsules, ointments, and liquids, further strengthening its presence in the vertigo treatment market. By increasing manufacturing capabilities, Marksans Pharma aims to meet the rising demand for effective vertigo treatments and expand its market share.
Major players in the vertigo treatment market are Pfizer Inc., Abbott Laboratories, Medtronic Plc, Boston Scientific Corp., Eisai Co. Ltd., Lupin Ltd., Vertigenius, Kracie Holdings Ltd., Biologische Heilmittel Heel GmbH, Interacoustics A/S., AdvaCare Pharma, AuroPharma Inc., Biofield Pharma Pvt Ltd., Sound Pharmaceuticals Inc., Otolith Labs Inc., Ear Technology Corporation, NeuroEquilibrium Diagnostic Systems Pvt Ltd., Vestibular First, Natus Medical Incorporated, Ronish Bioceuticals.
North America was the largest region in the vertigo treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in vertigo treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the vertigo treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The vertigo treatment market consists of revenues earned by entities by providing services such as diagnostic assessments, vestibular rehabilitation therapy, telemedicine consultations and personalized treatment plans. The market value includes the value of related goods sold by the service provider or included within the service offering. The vertigo treatment market also includes sales of anti-vertigo medications, anti-nausea medications, vestibular rehabilitation devices, wearable balance aids, diagnostic equipment and balance training apps. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Vertigo Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on vertigo treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for vertigo treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vertigo treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Peripheral Vertigo; Central Vertigo
2) By Treatment: Medication; Surgery; Therapy
3) By Route Of Administration: Oral; Topical; Parenteral; Other Routes Of Administration
4) By End User: Hospitals; Clinics; Other End Users
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Vertigo Treatment Market Characteristics
3. Vertigo Treatment Market Trends And Strategies
4. Vertigo Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Vertigo Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Vertigo Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Vertigo Treatment Market Growth Rate Analysis
5.4. Global Vertigo Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Vertigo Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Vertigo Treatment Total Addressable Market (TAM)
6. Vertigo Treatment Market Segmentation
6.1. Global Vertigo Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Peripheral Vertigo
Central Vertigo
6.2. Global Vertigo Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medication
Surgery
Therapy
6.3. Global Vertigo Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Topical
Parenteral
Other Routes Of Administration
6.4. Global Vertigo Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Other End Users
6.5. Global Vertigo Treatment Market, Sub-Segmentation Of Peripheral Vertigo, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Benign Paroxysmal Positional Vertigo (BPPV)
Meniere's Disease
Vestibular Neuritis
Labyrinthitis
6.6. Global Vertigo Treatment Market, Sub-Segmentation Of Central Vertigo, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Vestibular Migraine
Stroke-Related Vertigo
Multiple Sclerosis-Associated Vertigo
Brain Tumor-Related Vertigo
7. Vertigo Treatment Market Regional And Country Analysis
7.1. Global Vertigo Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Vertigo Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
